Project Details
Description
Development of natural killer cell based trispecific killer engagers (TriKEs) as novel immunotherapy for metastatic breast cancer
| Status | Finished |
|---|---|
| Effective start/end date | 3/30/20 → 5/20/23 |
Funding
- METAVIVOR RESEARCH AND SUPPORT, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.